Alkermes director reports routine RSU and option activity
Alkermes plc. director Nancy Lynn Snyderman, MD reported routine equity compensation activity and related tax withholding.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Alkermes plc. director Nancy Lynn Snyderman, MD reported routine equity compensation activity and related tax withholding. On May 21, 2026, she exercised a previously granted restricted stock unit award for 6,142 ordinary shares, and 1,475 shares were disposed of to cover tax obligations, not as an open-market sale.
On May 20, 2026, she received new equity awards: 5,409 restricted stock units, each representing the right to one ordinary share, and a non qualified stock option for 11,538 ordinary shares with a $36.98 exercise price expiring in 2036. A separate entry shows 20,783 ordinary shares held indirectly through the Nancy Lynn Snyderman Revocable Trust, where she is sole trustee and sole beneficiary.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit Award | 6,142 | $0.00 | $0.00 |
| Exercise | Ordinary Shares | 6,142 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Ordinary Shares | 1,475 | $36.95 | $55K |
| Grant/Award | Non Qualified Stock Option (Right to Buy) | 11,538 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Unit Award | 5,409 | $0.00 | $0.00 |
| holding | Ordinary Shares | -- | -- | -- |
Footnotes (4)
- F1. Each restricted stock unit represents a contingent right to receive one ordinary share.
- F2. Shares are held by the Nancy Lynn Snyderman Revocable Trust (the "Snyderman Trust"), of which the reporting person is both the sole trustee and sole beneficiary.
- F3. Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant.
- F4. This award is fully vested in accordance with its terms.
Key Figures
Key Terms
Restricted Stock Unit financial
Non Qualified Stock Option financial
tax-withholding disposition financial
derivative security financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Alkermes (ALKS) director Nancy Snyderman report?
Were Nancy Snyderman’s Alkermes (ALKS) transactions open-market buys or sells?
What new equity awards did Nancy Snyderman receive from Alkermes (ALKS)?
How does the tax-withholding disposition affect Nancy Snyderman’s Alkermes (ALKS) position?
What are the key dates and terms of Nancy Snyderman’s new Alkermes (ALKS) stock option?
AI-generated analysis. How Rhea-AI works. Not financial advice.